By Matt Grossman

Medtronic PLC said Thursday that it estimates organic sales growth will drive a higher adjusted profit in the coming fiscal year.

The Ireland-based medical-technology company forecast organic revenue growth of 9%, compared with full-year revenue of $30.12 billion in fiscal 2021. It forecast adjusted earnings of $5.60 to $5.75 a share.

Analysts surveyed by FactSet were anticipating fiscal 2022 revenue of $32.67 billion and adjusted earnings of $5.75 a share.

Write to Matt Grossman at matt.grossman@wsj.com

(END) Dow Jones Newswires

May 27, 2021 07:26 ET (11:26 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Medtronic Charts.